Patient Perception of Visual Distortions
- Conditions
- CataractAstigmatism
- Interventions
- Other: Administration of patient self-assessment
- Registration Number
- NCT02203747
- Lead Sponsor
- Abbott Medical Optics
- Brief Summary
The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 79
- Corneal astigmatism of at least 0.75 diopters
- Bilaterally-implanted with monofocal toric intraocular lenses in both eyes or with monofocal non-toric intraocular lenses in both eyes
- At least one month postoperative from second-eye surgery
- Ability to understand, read and write English to give consent and complete study questionnaire
- Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
- Sign informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
- Other protocol-defined inclusion criteria may apply
- Any ocular pathology of clinical significance, as determined by the investigator, other than regular corneal astigmatism, that may affect visual outcomes or influence subjective ocular visual symptoms
- Patient is pregnant or is lactating
- Participation in any other clinical trial during the last 30 days prior to study enrollment or concurrent participation in any other ongoing clinical trial
- Other protocol-defined exclusion criteria may apply
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Pseudophakic implanted with non-toric IOL Administration of patient self-assessment Subjects bilaterally implanted with non-toric IOL Pseudophakic implanted with toric IOL Administration of patient self-assessment Subjects bilaterally implanted with toric IOL
- Primary Outcome Measures
Name Time Method Visual Distortion Symptoms 1 week Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Contact AMO for Trial Locations
🇺🇸Santa Ana, California, United States